+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Next Generation Sequencing Market by Product Application, Technology, and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 4828627
  • Report
  • Region: Global
  • 369 pages
  • Allied Analytics LLP
1 of 3
The global next generation sequencing market size was valued at $4,533 million in 2018, and is estimated to reach $18,565 million by 2026, growing at a CAGR of 19.2% from 2019 to 2026.

Next generation sequencing (NGS) is a novel procedure for sequencing genomes at low costs and high speed with improved efficiency. NGS also known as deep sequencing and parallel sequencing is a technology that has revolutionized molecular biology and genomics research. It is a high throughput, non-Sanger based sequencing method. Next generation sequencing has made sequencing of genomes very rapid and cost-effective. Through this method, billions of DNA strands can be sequenced efficiently. Next generation sequencing has made it possible to conveniently sequence whole genomes, and analyze various DNA-protein interactions. This technique allows the researcher to focus, study, and interpret deep sequence target regions. Next generation sequencing can be utilized through varied interventions such as oncology, biomarker studies, drug discovery, understanding reproductive health, and personalized genomics.

Technological advancements in sequencing platforms, surge in applications of next generation sequencing, and increase in genome mapping programs drive the growth of the global next generation sequencing market. In addition, rise in awareness pertaining to next generation sequencing and increase in investment in research, development, and innovation supplement the market growth. However, lack of skilled professionals, ethical & legal limitation related to next generation sequencing, and standardization concerns in sequencing procedures impede the market growth. Furthermore, use of cloud computing as a potential data management service and untapped emerging economies offer lucrative opportunities for the market players.

The next generation sequencing market is segmented based on product, application, technology, end user, and region. Based on product, the market is divided into consumables, platforms, and services. The consumables product segment is further bifurcated as sample preparation consumables and other consumables. The sample preparation consumables are further segmented into DNA fragmentation, end repair, A-Tailing & size selection, library preparation & target enrichment, and quality control. The platform NGS product segment is classified into HiSeq, MiSeq, Ion Torrent, SOLiD, Pacbio Rs II & Sequel System, and other sequencing platforms. The services segment is divided into sequencing services and data management services. The sequencing services is further divided into RNA Sequencing, Whole Exome Sequencing, Whole Genome Sequencing, Targeted Sequencing, Chip Sequencing, De Novo Sequencing, and Methyl Sequencing. The data management services further divided into NGS data analysis services, NGS data analysis software & workbenches, and NGS storage, management & cloud computing solutions. Based on application, the market is divided into diagnostics, biomarkers and cancer, reproductive health, personalized medicine, agriculture and animal research, other applications. By Technology, market is segmented into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing, and other technologies. Depends on end user, market is categorized into academic & clinical research centers, pharmaceutical & biotechnology companies, hospitals & clinics, and other end user. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the next generation sequencing market in 2015, and is expected to retain its dominance throughout the forecast period. This is primarily attributed to higher buying power, availability, and applications that favor the utilization of NGS in this region. There is also an increase in agreements and collaborations between different market players and health centers to promote and utilize NGS in this region. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in R&D facilities, available disposable income, and rapidly developing economic conditions.

Product development is the key strategy adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global next generation sequencing market.

KEY MARKET BENEFITS
  • The study provides an in-depth analysis of the global next generation sequencing market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • The report presents quantitative analysis of the market for the period of 2014–2022 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on product type assists in understanding the trends in the industry.
  • Key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry
KEY MARKET SEGMENTS
  • By Product
o Consumables
  • Sample Preparation Consumables
  • DNA Fragmentation, End Repair, A-Tailing and Size Selection
  • Library Preparation & Target Enrichment
  • Quality Control
  • Other Consumables
o Platforms
  • HiSeq
  • MiSeq
  • Ion Torrent
  • SOLiD
  • Pacbio Rs II and Sequel System
  • Other Sequencing Platforms
o Services
  • Sequencing Services
  • RNA Sequencing
  • Whole Exome Sequencing
  • Whole Genome Sequencing
  • Targeted Sequencing
  • Chip Sequencing
  • De Novo Sequencing
  • Methyl Sequencing
  • Data Management Services
  • NGS Data Analysis Services
  • NGS Data Analysis Software & Workbenches
  • NGS Storage, Management and Cloud Computing Solutions
  • By Application
o Diagnostics
o Biomarkers and Cancer
o Reproductive Health
o Personalized Medicine
o Agriculture and Animal Research
o Other Applications
  • By Technology
o Sequencing by Synthesis
o Ion Semiconductor Sequencing
o Sequencing by Ligation
o Pyrosequencing
o Single Molecule Real Time Sequencing
o Other Technologies
  • By End User
o Academic and Clinical Research Centers
o Pharmaceutical and Biotechnology Companies
o Hospitals and Clinics
o Other End User
  • By Region
o North America
  • U.S.
  • Canada
  • Mexico
o Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
o Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Taiwan
  • Rest of Asia-Pacific
o LAMEA
  • Brazil
  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
KEY PLAYERS PROFILED
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Pacific Biosciences of California, Inc.
  • Beijing Genomics Institute
  • Qiagen N.V.
  • 454 Life Sciences Corporation (Roche Holding AG)
  • Agilent Technologies, Inc.
  • Perkinelmer, Inc.
  • Genomatix GmbH
  • PierianDx
Other players in the value chain include (profiles not included in the report)
  • Eurofins Scientific
  • Gatc Biotech AG
  • Macrogen, Inc.
  • Oxford Nanopore Technologies, Ltd.
  • Bio-Rad Laboratories, Inc.
  • DNASTAR, Inc.
  • Biomatters Ltd.
  • Partek Inc.
  • New England Biolabs, Inc.
  • Myriad Genetics, Inc.
Note: Product cover images may vary from those shown
2 of 3
CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective
2.2. Key findings

2.2.1. Top impacting factors
2.2.2. Top investment pockets

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Parent Market Overview
3.3. Key Forces Shaping Next generation sequencing Market

3.3.1. Moderate bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. High bargaining power of buyers

3.4. Pricing Analysis

3.4.1. Pricing Analysis, By Region, 2018 & 2026

3.5. Market Evolution
3.6. Value Chain Analysis
3.7. Impact of Government Regulations on Global Next Generation Sequencing Market
3.8. Patent Analysis (2016-2018)

3.8.1. Patent Analysis, by Year
3.8.2. By Country
3.8.3. By Applicant

3.9. Case Studies

3.9.1. Case Study 01

3.10. Market dynamics

3.10.1. Drivers

3.10.1.1. Technological advancements in NGS
3.10.1.2. Surge in applications of NGS
3.10.1.3. Increase in partnerships and collaborations
3.10.1.4. Increase in genome mapping programs

3.10.2. Restraints

3.10.2.1. Standardization concerns over NGS based diagnostics
3.10.2.2. Lack of skilled professionals
3.10.2.3. Ethical and legal limitations

3.10.3. Opportunities

3.10.3.1. Lucrative opportunities in emerging markets
3.10.3.2. Cloud computing: potential data management service

CHAPTER 4: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT

4.1. Overview
4.2. Market size and forecast
4.3. Consumables

4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by type

4.3.2.1. Sample preparation consumables

4.3.2.1.1. Market size and forecast, by type

4.3.2.1.1.1. DNA Fragmentation, End Repair, A-Tailing and Size Selection

4.3.2.1.1.1.1. Market size and forecast

4.3.2.1.1.2. Library preparation & target enrichment

4.3.2.1.1.2.1. Market size and forecast

4.3.2.1.1.3. Quality Control

4.3.2.1.1.3.1. Market size and forecast

4.3.2.2. Other Consumables

4.3.2.2.1. Market size and forecast

4.3.3. Market size and forecast, by region
4.3.4. Market analysis by country

4.4. Platforms

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by type

4.4.2.1. HiSeq series

4.4.2.1.1. Market size and forecast

4.4.2.2. MiSeq series

4.4.2.2.1. Market size and forecast

4.4.2.3. ION Torrent

4.4.2.3.1. Market size and forecast

4.4.2.4. SOLiD

4.4.2.4.1. Market size and forecast

4.4.2.5. Pacbio Rs II and Sequel system

4.4.2.5.1. Market size and forecast

4.4.2.6. Other Sequencing Platforms

4.4.2.6.1. Market size and forecast

4.4.3. Market size and forecast, by region
4.4.4. Market analysis by country

4.5. Services

4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by type

4.5.2.1. Sequencing Services

4.5.2.1.1. Market size and forecast, by type

4.5.2.1.1.1. RNA Sequencing

4.5.2.1.1.1.1. Market size and forecast

4.5.2.1.1.2. Whole exome sequencing

4.5.2.1.1.2.1. Market size and forecast

4.5.2.1.1.3. Whole genome sequencing

4.5.2.1.1.3.1. Market size and forecast

4.5.2.1.1.4. Targeted sequencing

4.5.2.1.1.4.1. Market size and forecast

4.5.2.1.1.5. Chip sequencing

4.5.2.1.1.5.1. Market size and forecast

4.5.2.1.1.6. De Novo sequencing

4.5.2.1.1.6.1. Market size and forecast

4.5.2.1.1.7. Methyl sequencing

4.5.2.1.1.7.1. Market size and forecast

4.5.2.2. Data management services

4.5.2.2.1. Market size and forecast, by type

4.5.2.2.1.1. NGS Data Analysis Services

4.5.2.2.1.1.1. Market size and forecast

4.5.2.2.1.2. NGS data analysis software & workbenches

4.5.2.2.1.2.1. Market size and forecast

4.5.2.2.1.3. NGS storage, management, and cloud computing solutions

4.5.2.2.1.3.1. Market size and forecast

4.5.3. Market size and forecast, by region
4.5.4. Market analysis by country

CHAPTER 5: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION

5.1. Overview
5.2. Market size and forecast
5.3. Biomarkers and Cancer

5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country

5.4. Diagnostics

5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country

5.5. Reproductive Health

5.5.1. Market size and forecast, by region
5.5.2. Market analysis by country

5.6. Personalized Medicine

5.6.1. Market size and forecast, by region
5.6.2. Market analysis by country

5.7. Agriculture and Animal Research

5.7.1. Market size and forecast, by region
5.7.2. Market analysis by country

5.8. Other Applications

5.8.1. Market size and forecast, by region
5.8.2. Market analysis by country

CHAPTER 6: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY

6.1. Overview
6.2. Market size and forecast
6.3. Sequencing by Synthesis (SBS)

6.3.1. Market size and forecast, by region
6.3.2. Market analysis by country

6.4. Ion Semiconductor Sequencing (IOS)

6.4.1. Market size and forecast, by region
6.4.2. Market analysis by country

6.5. Sequencing by Ligation (SBL)

6.5.1. Market size and forecast, by region
6.5.2. Market analysis by country

6.6. Pyrosequencing

6.6.1. Market size and forecast, by region
6.6.2. Market analysis by country

6.7. Single-Molecule-Real-Time Sequencing (SMRT)

6.7.1. Market size and forecast, by region
6.7.2. Market analysis by country

6.8. Other Technologies

6.8.1. Market size and forecast, by region
6.8.2. Market analysis by country

CHAPTER 7: NEXT GENERATION SEQUENCING MARKET, BY END USER

7.1. Overview
7.2. Market size and forecast
7.3. Academic and Clinical Research Centers

7.3.1. Market size and forecast, by region
7.3.2. Market analysis by country

7.4. Pharmaceutical and Biotechnology Companies

7.4.1. Market size and forecast, by region
7.4.2. Market analysis by country

7.5. Hospitals and Clinics

7.5.1. Market size and forecast, by region
7.5.2. Market analysis by country

7.6. Other End Users

7.6.1. Market size and forecast, by region
7.6.2. Market analysis by country

CHAPTER 8: NEXT GENERATION SEQUENCING MARKET, BY REGION

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. North America

8.2.1. Key market trends and opportunities
8.2.2. North America next generation sequencing market, by country

8.2.2.1. U.S. next generation sequencing market, by product
8.2.2.2. U.S. next generation sequencing market, by application
8.2.2.3. U.S. next generation sequencing market, by technology
8.2.2.4. U.S. next generation sequencing market, by end user
8.2.2.5. Canada next generation sequencing market, by product
8.2.2.6. Canada next generation sequencing market, by application
8.2.2.7. Canada next generation sequencing market, by technology
8.2.2.8. Canada next generation sequencing market, by end user
8.2.2.9. Mexico next generation sequencing market, by product
8.2.2.10. Mexico next generation sequencing market, by application
8.2.2.11. Mexico next generation sequencing market, by technology
8.2.2.12. Mexico next generation sequencing market, by end user

8.2.3. North America next generation sequencing market, by product
8.2.4. North America next generation sequencing market, by application
8.2.5. North America next generation sequencing market, by technology
8.2.6. North America next generation sequencing market, by end user
8.2.7. Europe
8.2.8. Key market trends and opportunities
8.2.9. Europe next generation sequencing market, by country

8.2.9.1. Germany next generation sequencing market, by product
8.2.9.2. Germany next generation sequencing market, by application
8.2.9.3. Germany next generation sequencing market, by technology
8.2.9.4. Germany next generation sequencing market, by end user
8.2.9.5. France next generation sequencing market, by product
8.2.9.6. France next generation sequencing market, by application
8.2.9.7. France next generation sequencing market, by technology
8.2.9.8. France next generation sequencing market, by end user
8.2.9.9. Italy next generation sequencing market, by product
8.2.9.10. Italy next generation sequencing market, by application
8.2.9.11. Italy next generation sequencing market, by technology
8.2.9.12. Italy next generation sequencing market, by end user
8.2.9.13. UK next generation sequencing market, by product
8.2.9.14. UK next generation sequencing market, by application
8.2.9.15. UK next generation sequencing market, by technology
8.2.9.16. UK next generation sequencing market, by end user
8.2.9.17. Rest of Europe next generation sequencing market, by product
8.2.9.18. Rest of Europe next generation sequencing market, by application
8.2.9.19. Rest of Europe next generation sequencing market, by technology
8.2.9.20. Rest of Europe next generation sequencing market, by end user

8.2.10. Europe next generation sequencing market, by product
8.2.11. Europe next generation sequencing market, by application
8.2.12. Europe next generation sequencing market, by technology
8.2.13. Europe next generation sequencing market, by end user

8.3. Asia-Pacific

8.3.1. Key market trends and opportunities
8.3.2. Asia-Pacific next generation sequencing market, by country

8.3.2.1. Australia next generation sequencing market, by product
8.3.2.2. Australia next generation sequencing market, by application
8.3.2.3. Australia next generation sequencing market, by technology
8.3.2.4. Australia next generation sequencing market, by end user
8.3.2.5. Japan next generation sequencing market, by product
8.3.2.6. Japan next generation sequencing market, by application
8.3.2.7. Japan next generation sequencing market, by technology
8.3.2.8. Japan next generation sequencing market, by end user
8.3.2.9. India next generation sequencing market, by product
8.3.2.10. India next generation sequencing market, by application
8.3.2.11. India next generation sequencing market, by technology
8.3.2.12. India next generation sequencing market, by end user
8.3.2.13. China next generation sequencing market, by product
8.3.2.14. China next generation sequencing market, by application
8.3.2.15. China next generation sequencing market, by technology
8.3.2.16. China next generation sequencing market, by end user
8.3.2.17. South Korea next generation sequencing market, by product
8.3.2.18. South Korea next generation sequencing market, by application
8.3.2.19. South Korea next generation sequencing market, by technology
8.3.2.20. South Korea next generation sequencing market, by end user
8.3.2.21. Taiwan next generation sequencing market, by product
8.3.2.22. Taiwan next generation sequencing market, by application
8.3.2.23. Taiwan next generation sequencing market, by technology
8.3.2.24. Taiwan next generation sequencing market, by end user
8.3.2.25. Rest of Asia-Pacific next generation sequencing market, by product
8.3.2.26. Rest of Asia-Pacific next generation sequencing market, by application
8.3.2.27. Rest of Asia-Pacific next generation sequencing market, by technology
8.3.2.28. Rest of Asia-Pacific next generation sequencing market, by end user

8.3.3. Asia-Pacific next generation sequencing market, by product
8.3.4. Asia-Pacific next generation sequencing market, by application
8.3.5. Asia-Pacific next generation sequencing market, by technology
8.3.6. Asia-Pacific next generation sequencing market, by end user

8.4. LAMEA

8.4.1. Key market trends and opportunities
8.4.2. LAMEA next generation sequencing market, by country

8.4.2.1. Brazil next generation sequencing market, by product
8.4.2.2. Brazil next generation sequencing market, by application
8.4.2.3. Brazil next generation sequencing market, by technology
8.4.2.4. Brazil next generation sequencing market, by end user
8.4.2.5. Saudi Arabia next generation sequencing market, by product
8.4.2.6. Saudi Arabia next generation sequencing market, by application
8.4.2.7. Saudi Arabia next generation sequencing market, by technology
8.4.2.8. Saudi Arabia next generation sequencing market, by end user
8.4.2.9. South Africa next generation sequencing market, by product
8.4.2.10. South Africa next generation sequencing market, by application
8.4.2.11. South Africa next generation sequencing market, by technology
8.4.2.12. South Africa next generation sequencing market, by end user
8.4.2.13. Rest of LAMEA next generation sequencing market, by product
8.4.2.14. Rest of LAMEA next generation sequencing market, by application
8.4.2.15. Rest of LAMEA next generation sequencing market, by technology
8.4.2.16. Rest of LAMEA next generation sequencing market, by end user

8.4.3. LAMEA next generation sequencing market, by product
8.4.4. LAMEA next generation sequencing market, by application
8.4.5. LAMEA next generation sequencing market, by technology
8.4.6. LAMEA next generation sequencing market, by end user

CHAPTER 9: COMPETITIVE LANDSCAPE

9.1. Introduction
9.2. Market Share Analysis of Top Players, 2018 (%)
9.3. Product Mapping of Top 10 Player

CHAPTER 10: COMPANY PROFILES

10.1. AGILENT TECHNOLOGIES, INC.

10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Operating business segments
10.1.4. Product portfolio
10.1.5. Business performance
10.1.6. Key strategic moves and developments

10.2. BEIJING GENOMICS INSTITUTE

10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Operating business segments
10.2.4. Product portfolio
10.2.5. Key strategic moves and developments

10.3. F. HOFFMANN-LA ROCHE LTD.

10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Product portfolio
10.3.5. Business performance
10.3.6. Key strategic moves and developments

10.4. ILLUMINA, INC.

10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Operating business segments
10.4.4. Product portfolio
10.4.5. Business Performance
10.4.6. Key strategic moves and developments

10.5. INTREXON CORPORATION (Intrexon Bioinformatics Germany GMBH)

10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Product portfolio
10.5.5. Business Performance

10.6. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Product Portfolio
PacBio offers various NGS products through its services:
10.6.5. Business performance
10.6.6. Key strategic moves and developments

10.7. PERKINELMER, INC.

10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Product portfolio
10.7.5. Business performance
10.7.6. Key strategic moves and developments

10.8. PIERIANDX

10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Product portfolio
10.8.5. Key strategic moves and developments

10.9. QIAGEN N.V.

10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Product portfolio
10.9.5. Business performance
10.9.6. Key strategic moves and developments

10.10. THERMO FISHER SCIENTIFIC, INC.

10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Operating business segments
10.10.4. Product portfolio
10.10.5. Business performance
10.10.6. Key strategic moves and developments

*Full List of Tables and Figures Available on Enquiry.

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll